NewAmsterdam Pharma Company N.V. (NAMS) Capital expenditures 2021–2025
NewAmsterdam Pharma Company N.V. (NAMS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$246,000FY2025 · since FY2021: $24,000 → $246,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $246,000 | -63.4% |
| FY2024 | $672,000 | +2700.0% |
| FY2023 | $24,000 | -89.1% |
| FY2022 | $221,000 | +820.8% |
| FY2021 | $24,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice